0001140361-21-009211.txt : 20210318
0001140361-21-009211.hdr.sgml : 20210318
20210318211846
ACCESSION NUMBER: 0001140361-21-009211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210315
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bespalko David William
CENTRAL INDEX KEY: 0001848740
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35569
FILM NUMBER: 21756282
MAIL ADDRESS:
STREET 1: 29 CEDAR DRIVE
CITY: ALLENDALE
STATE: NJ
ZIP: 07401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC.
CENTRAL INDEX KEY: 0001092662
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880425691
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
BUSINESS PHONE: (631) 924-1135
MAIL ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
FORMER COMPANY:
FORMER CONFORMED NAME: Chembio Diagnostics Inc.
DATE OF NAME CHANGE: 20040607
FORMER COMPANY:
FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC
DATE OF NAME CHANGE: 19990805
4
1
form4.xml
FORM 4
X0306
4
2021-03-15
0001092662
CHEMBIO DIAGNOSTICS, INC.
CEMI
0001848740
Bespalko David William
C/O CHEMBIO DIAGNOSTICS, INC.
555 WIRELESS BOULEVARD
HAUPPAUGE
NY
11788
true
Restricted Stock Units
2021-03-15
4
A
0
17204
0
A
Common Stock
17204
17204
D
Nonqualified Stock Options
4.65
2021-03-15
4
A
0
31746
0
A
2028-03-14
Common Stock
31746
31746
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
The restricted stock units are scheduled to vest in three equal installments on March 15 of each of 2022, 2023 and 2024, provided they shall vest in full immediately prior to a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer), subject to continued service through each vesting date.
The nonqualified stock options are scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2022 annual meeting of stockholders of the issuer and (ii) a Change in Control, subject to continued service through each vesting date.
/s/ Mark L. Johnson, Attorney-in-Fact for David William Bespalko
2021-03-18